Detalhe da pesquisa
1.
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
N Engl J Med
; 384(20): 1899-1909, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951374
2.
Rifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349).
Clin Infect Dis
; 76(3): e580-e589, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36041016
3.
1-Year Incidence of Tuberculosis Infection and Disease Among Household Contacts of Rifampin- and Multidrug-Resistant Tuberculosis.
Clin Infect Dis
; 77(6): 892-900, 2023 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37227925
4.
Efavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine.
Clin Infect Dis
; 75(4): 560-566, 2022 09 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34918028
5.
Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis Coinfection.
Clin Infect Dis
; 73(4): 706-715, 2021 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34398956
6.
Correlates and Timing of Reproductive Aging Transitions in a Global Cohort of Midlife Women With Human Immunodeficiency Virus: Insights From the REPRIEVE Trial.
J Infect Dis
; 222(Suppl 1): S20-S30, 2020 07 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32645159
7.
Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study.
Clin Infect Dis
; 70(3): 436-445, 2020 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30919881
8.
Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease.
Clin Infect Dis
; 70(3): 425-435, 2020 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30942853
9.
Human Immunodeficiency Virus Type 1 and Tuberculosis Coinfection in Multinational, Resource-limited Settings: Increased Neurological Dysfunction.
Clin Infect Dis
; 68(10): 1739-1746, 2019 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30137250
10.
Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study.
J Infect Dis
; 215(6): 907-910, 2017 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28453835
11.
HIV and COPD: a conspiracy of risk factors.
Respirology
; 21(7): 1166-72, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27237114
12.
Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.
Clin Infect Dis
; 60(10): 1541-9, 2015 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25681380
13.
Differences in antiretroviral safety and efficacy by sex in a multinational randomized clinical trial.
HIV Clin Trials
; 16(3): 89-99, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25979186
14.
Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide.
Proc Natl Acad Sci U S A
; 109(37): 15001-5, 2012 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-22927424
15.
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.
N Engl J Med
; 365(16): 1482-91, 2011 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22010914
16.
HIV transmission risk behavior among HIV-positive patients receiving antiretroviral therapy in KwaZulu-Natal, South Africa.
AIDS Behav
; 18(8): 1532-40, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24158486
17.
Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission.
J Infect Dis
; 208(4): 662-71, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23687222
18.
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study.
Lancet HIV
; 11(5): e300-e308, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621393
19.
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.
Lancet Infect Dis
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768617
20.
Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group.
PLoS One
; 18(2): e0281580, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780493